contact: Newcode @ aol.com
Dr. Merrill Garnett is the founder and director of Garnett McKeen Laboratory, Inc. Holding a D.D.S. from New York University, and graduate study in chemistry and biochemistry, Dr. Garnett has had research laboratories at the Central Islip State Hospital, Waldemar Medical Research Foundation, Northport Veterans' Administration Medical Center, and the High Technology Incubator of The State University of New York at Stony Brook.

Dr. Garnett's principle laboratory discoveries reveal the presence of corollary dynamics of the genetic code by which specific DNA coded segments and cell membranes exchange ultra-low frequency sinusoidal electrical currents. According to his theory, these pulsed currents are the basis of all physiological pulses and determine the polarization, charge and folding of enzymes, nucleic acids and membrane phospholipids. The restoration of these charge transfer pathways form the basis of several new methods of medicinal management.

Investigators at the University of Utah and Columbia University have collaborated in studies of his compound, DNA Reductase. This is the first non-toxic chemotherapeutic agent, a liquid crystal complex  of palladium and lipoic acid. Other new drugs are also under development. Dr. Garnett has been issued three United States patents related to the treatment of tumors and psoriasis.

Curriculum Vitae + Current Bibliography

For a list of publications, abstracts and technical writings please go to:  Electrogenetics.net